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CHAPTER 1
INTRODUCTION
One of the growing concerns in today's society is
the adverse effects of stress. Stress consists of both
cognitive and physiological components. A cognitive
emotional aspect of stress is anxiety which can be
examined through physiological measures such as heart
rate, blood pressure, and muscle tension.
Electromyography (EMG) is a common technique used in
measuring muscle tension. This method records electrical
activity of muscle action potentials (MAP's) which
indicate potential muscle tension. MAP's are the
ionically produced electrical activity involved in muscle
contraction. The level of electrical activity in a
muscle will approximate total body tension (deVries,
Wiswell, Bulbulian, & Moritani, 1981). Another
indication of muscle tension and a measure of spinal
reflex activity is the Hoffman reflex (H-reflex)
,
typically induced by artificial electrical stimulation of
the tibial nerve in humans.
Some evidence points to exercise as an effective
means of reducing muscle tension. deVries (1968) , for
example, found both acute and chronic exercise led to
decreased electrical activity in resting muscle action
potentials (MAP's) as measured by by the H-reflex
(deVries, Wiswell, Bulbulian, & Moritani, 1981). To
control for H-wave variations due to stimulus changes.
the H/M ratio was developed by dividing the maximum H-
wave by the maximum M-wave (produced by direct
stimulation of the alpha motoneuron) (Angel & Hofmann,
1963) . While low and high intensity exercise showed
decreases in the H/M ratio, high intensity exercise in
particular appears more proficient in reducing muscle
tension (Bulbulian & Darabos, 1986) . These findings have
led several researchers to conclude that reductions in
H/M ratios were due to a "tranquilizer effect" (a
decrease in neuromuscular tension) as a result of
exercise (deVries et al., 1981; Bulbulian & Darabos,
1986) .
Possible explanations of an exercise induced
tranquilizer effect include: a) exercise induced heating
of the hypothalamus and body to produce diminished muscle
spindle activity coincident with synchronous cortical
electrical events (Von Euler & Soderberg, 1956)
,
b) varied, periodic, and continual alterations in
proprioceptive stimuli during exercise which allow normal
activity of the cortex (Haugen, Dixon, & Dickel, i960),
and c) endorphin release during exercise also believed to
produce a "morphine-like" effect (Morgan, 1985)
.
The tranquilizer effect of pharmacological agents
also shows reductions of the H-reflex (Brunia, 1973)
.
Therefore, a comparison between drugs and exercise as
muscle relaxants would seem appropriate. Comparing the
effects of exercise and meprobamate, a muscle relaxant,
deVries and Adams (1972) indicated that exercise more
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effectively reduced muscular tension than meprobamate
.
Conclusions suggest that exercise at 100 BPM brought
about greater reductions in muscle tension than higher
intensity exercise (120 BPM) and meprobamate. However,
noting that both the plasma concentrations and
physiological effects of meprobamate peak within 2-3
hours after ingestion (Goodman & Oilman, 1975) post-
tests occurring 30-90 minutes after drug administration
did not allow sufficient time for meprobamate effects to
take place. Therefore, interpretation of these data
should be approached with caution.
A fast acting anti-anxiety benzodiazepine,
triazolam, may overcome the problem of slow activation
seen in meprobamate (Greenblatt, Divoll, Abernathy, &
Shader, 1982)
.
Triazolam, introduced in 1981, reaches
peak blood concentrations at approximately 3 minutes
post- ingestion (Pugsley & Cohon, 1982) . Using triazolam
should produce decreased neuromuscular tension concurrent
with exercise induced relaxation since the peak exercise
effects occur at 3 minutes. This information infers
that triazolam could produce greater changes in muscle
tension reduction than meprobamate.
Purpose of the Study
The purpose of this study was to examine the effects
of exercise and triazolam on the neuromuscular tension
and motoneuron excitability as measured by H/M ratios.
Hypotheses
The following hypotheses were tested:
1) Subjects using triazolam will show a greater
reduction in H/M ratios than subjects using the placebo.
2) Subjects performing moderate to high intensity
exercise will show a greater reduction in H/M ratios than
subjects using triazolam or the placebo without
exercising.
3) Subjects using both triazolam and exercise will
show a greater reduction in H/M ratios than subjects
using triazolam or exercise alone.
Delimitations
The following delimitations are given because they
restrict the extent that the conclusions may be validly
generalized:
1) Subjects were eight college male volunteers,
aged 22-30 years.
2) Participation was limited to competitive or
recreational runners able to complete 2 minutes of
running on the treadmill at 75% of V02max.
3) The H/M ratio measured motoneuron pool
excitability during artificial electrical stimulation of
the soleus muscle.
4) Triazolam was administered in .25 mg doses.
Limitations
The following limitations may have diminished the
validity of this study:
1) Daily variations in emotional states of subjects
may have influenced H/M ratios during testing.
2) The H/M ratios may include the measurement of
both the triceps surae and peroneals.
3) The H/M ratio is a measurement of motoneuron pool
excitability and infers changes in neuromuscular tension.
Definition of Terms
The following section will define several terms
within this text to prevent ambiguous interpretation:
Muscle Action Potentials (MAP's) : The exchange of
counter-ions across the cellular membrane created by
neural suprathreshold stimulation which ultimately
produces muscle contraction.
Electromyography (EMG) : The recording of electrical
events between two surface electrodes resulting from
muscle action potentials.
Hoffman Reflex (H-reflex) : The reflex response
which results from artificial electrical stimulation of a
mixed nerve.
M-wave : A contraction in response to direct
stimulation of motor fibers in skeletal muscle.
H/M Ratio : The ratio produced by dividing the
maximum H-wave by the maximum M-wave measured.
Maximal Oxygen Consumption (V02max) : The maximum
rate of oxygen consumption by the body during work.
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CHAPTER 2
LITERATURE REVIEW
A review of the literature regarding decreases in
anxiety and neuromuscular tension facilitated by exercise
will be presented in this chapter. Measurement
techniques for muscle tension and decreased motoneuron
excitability will be introduced in unison with literature
which demonstrates this occurrence. Finally, the
physiological rationale for muscle tension reduction and
the tranquilizer effect of exercise will be discussed.
Use of the H/M Ratio as a Measure of Stress
The Hoffmann reflex (H-reflex) measures spinal
reflexes which reflect muscle tension associated with
stress (Angel & Hofmann, 1963 ; deVries, 1981; Dishman,
1985)
.
In a study by Magladery, Porter, Park, and
Teasdall (1951) stimulation of afferent fibers of the
tibial nerve produced muscle action potentials whose
magnitude was believed to indicate central inhibition or
excitation on reflexes. The reflex muscle action
potentials produced from artificial electrical
stimulation of mixed nerve fibers in the soleus muscle is
known as the Hoffmann reflex or H-reflex. The H-reflex
is the result of an action potential created by
artificial electrical stimulation. This is achieved by
an electrical impulse delivered to the tibial nerve at
the popliteal fossa. The electrical shock given will
elicit two MAP'S which are recorded by an oscilloscope.
By studying the electric waves produced by these MAP'S,
motoneuron excitability may be determined (Angel &
Hofmann, 1963) . The first wave recorded is the M-wave
which results from direct stimulation of the alpha motor
fibers. After a slight delay the H-wave or H-reflex will
appear. Formation of this complex occurs through
electrical impulses traveling along the afferent nerve to
the central nervous system (CNS) and back down the
efferent pathway (alpha motor neuron) to the same muscle
which stimulates contraction. The size of the second MAP
(H-reflex) is an indication of motoneuron excitability
and reflects the level of muscle tension in a subject.
According to Crayton and King (1981) the H-reflex is high
in individual variability. When using this measure as an
indicator of motoneuron excitability caution must be
taken to ensure factors other than neuromuscular tension
do not contaminate the results. For example, Issacs and
Szumski (1968) tested four variables and their influence
on the H-reflex. Results indicated that a Jendrassik
manuever (muscular contractions which enhance reflex
excitability) and postural changes altered the H-reflex.
Hugon (1973) also noted that proper body positioning and
correct soleus electrode placement are essential for
reliable recordings.
Angel and Hofmann (1963) developed a variation of
the H-reflex believed to be more useful and accurate.
They measured normal, rigid, and spastic subjects from
which they concluded that: a) absolute values of the H-
7
wave were affected by skin thickness and electrode
placement, and b) one stimulus intensity allowed large
variations in the size of H- and M-waves. By measuring
the maximal H-wave and M-wave and then dividing these
values, the H/M ratio was derived. Since the maximum M-
wave is acquired through direct stimulation it has a
constant value due to 100% recruitment of the motor
fibers. The H-wave, achieved only after passing through
the CNS, is subject to various levels of excitation or
inhibition. Therefore, any change in the H/M ratio
indicates a change in motoneuron excitability or
neuromuscular tension. Experimental reproductions of H/M
ratios by changing stimulus intensity would mimic
different electrical levels in muscle. By increasing the
stimulus strength the H-wave will also be elevated. If
the experimenter increases the stimulus to levels greater
than the maximum H-wave it will begin to disappear
simultaneously as the M-wave increases (Hugon, 1973;
Magladery et al., 1951). When the M-wave is at maximum
amplitude the H-wave is nonexistent suggesting a blocking
effect of antidromic impulses in motoneurons (Magladery
et al., 1951). Therefore, stimulus strength must be
increased slowly or the H-reflex may be overlooked.
Hugon (1973) suggested that the maximum M-wave first be
dicovered, then a retracing back through lower voltages
will bring back the H-wave. Once these procedures have
been properly executed an accurate assessment of a
8
subjects neuromuscular tension may be interpreted.
Anxiety and Neuromuscular Tension Reduction
In a review article by Dishman (1985) , both acute
and chronic exercise are cited as decreasing levels of
anxiety. Morgan (1985) suggested this effect may last
from 2-5 hours. The National Institute of Mental Health
also contends that: a) exercise is associated with
cognitive stress reductions such as in anxiety, b) long
term exercise decreases anxiety, and c) appropriate
execise will result in decreased muscle tension.
Anxiety is often noted by subjective feelings of
increased muscle tension (Bahrke, 1979) . Therefore,
studies which have tested both anxiety and muscle tension
reduction were performed. Sime (1977) tested the effect
of exercise, meditation, and a placebo treatment on
reducing several stress-related physiological measures
and state anxiety. Subjects were 48 students who
reported state anxiety. Measures of state anxiety were
made during pre- and post-treatment. Physiological
measures were performed at the same time with an
additional recording during the test. Students were
randomly placed into groups which consisted of:
a) exercise on a treadmill at a heart rate (HR) of 100-
110 beats per minute (BPM) , b) meditation for 15 minutes,
and c) a control placebo pill. Results indicated state
anxiety was lower (although not significantly) for
exercise and meditation groups. Electromyography (EMG)
data indicated that all treatment groups decreased muscle
9
tension.
The former results may have prompted a more
substantial study by Bahrke and Morgan (1978) . They
compared three separate conditions to find their effects
on muscle tension and state anxiety as defined by the
State Trait Anxiety Inventory (STAI) . Adult males (n=75)
were placed into three experimental groups which received
treatment during 2 minutes under each condition. These
groups consisted of: 1) walking on a treadmill at 70%
V02max, 2) meditation, and 3) a distraction group which
rested quietly. All groups possessed similar
capabilities in reducing state anxiety according to the
STAI scores. The anti-anxiety effect of distraction and
exercise are initially equal, however, tension reduction
following exercise has a much longer lasting effect.
Review articles and previously cited evidence agree
that a reduction in state anxiety can effectively be
brought about through the use of various types of
exercise (Dishman, 1985; Morgan, 1985).
Exercise and the H/M Ratio
Recent studies utilizing the H/M ratio as an
indicator of neuromuscular tension have met with
generally successful results. A study by deVries,
Wiswell, Bulbulian, and Moritani (1931) attempted to
measure what they termed a "tranquilizer effect" of
exercise since tranquilizers are known to reduce the H/M
ratio. Subjects included two elderly subjects (ages 66
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and 80) with chronic stress related conditions and eight
young (2 0-34 years) adults. Subjects were tested on
three different days before and after exercise and
control conditions. Exercise consisted of 2 minutes of
cycling on a bicycle ergometer at 40% of heart rate range
(HRR)
. The control condition consisted of 2 minutes of
sitting quietly. Motoneuron excitability decreased
following exercise as shown by a mean reduction of 18.7%
in the H/M ratio. Following the control trial an
insignificant mean increase of 1.2% was shown. This
significant decrease in the H/M ratio occurred in all
subjects which supports a generalized neuromuscular
relaxation or tranquilizer effect. Thus, it was
concluded that low intensity exercise continued for at
least 20 minutes produced a reduction in neuromuscular
tension.
A similar study, recently completed, tested the H/M
ratio following both low and high intensity exercise.
Bulbulian and Darabos (1986) proposed that the previous
evidence negating the importance of high inters ity
exercise was invalid. Pitts and McClure (1967) , for
example, prompted anxiety attacks in twenty neurotic
patients by infusing dl-sodium lactate. They concluded
these induced lactate levels would simulate those
attained during strenuous exercise. However, deVries
(1981) cited several inconsistencies with Pitts and
McClure 's assumptions in his review on the tranquilizer
effect of exercise. deVries (1981) questioned whether:
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a) endogenous lactate differs in composition from dl-
sodium lactate, b) highly anxious individuals to possess
a high resting level of lactate, and c) whether it is not
consistent for patients with anxiety neurosis to have
anxiety attacks due to high lactate levels. Bulbulian
and Darabos (1986) investigated the relationship between
high lactate levels and anxiety. Their subjects were five
males and five females measured before and after each
treatment by the H/M ratio. After a control period of
sitting quietly, subjects ran on a treadmill for 20
minutes at 40% of V02max and then 75% of V02max. Results
indicated H/M ratios decreased after both exercise
trials. The low intensity exercise resulted in a mean
decrease of 12.8% while the high intensity group showed a
reduction of 21.5%. The control group exhibited an
insignificant mean increase of 2.1%. The results of this
study suggest that high intensity exercise more
effectively reduced muscle tension than low intensity
exercise.
Proposed Mechanisms for Exercise Induced Relaxation
Although the previously mentioned studies present
evidence of decreased muscle tension, the physiological
mechanisms of decreased muscle tension have not been
addressed. This section, therefore, addresses possible
physiological explanations for muscle relaxation.
Heat
. Several studies cite the work of Von Euler and
Soderburg (1956; 1957) as one possible explanation for
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exercise tension reduction. In their animal studies they
noted drowsiness and muscular relaxation resulting from
an increase in hypothalamic and total body temperature.
deVries (1968) , utilizing this theory in his study
postulated that exercise would increase body temperature,
and as a result, decrease neuromuscular activity. Two
processes for this reduction were proposed: a) decreased
cortical activity should decrease alpha innervation of
muscles, and b) gamma activity on intrafusal fiber should
decrease muscle activity. An elevation of heat would be
quite evident in high intensity exercise, but may not
occur in low intensity exercise. However, a recent study
by Bowles (1987) found that metabolically matched
concentric and eccentric work produced unequal post- H/M
ratio reductions. Matched work should produce similar
temperature responses and therefore equal changes in
motoneuron excitability. This new evidence suggests that
body temperature may not be a primary causal mechanism
for decreased motoneuron pool excitability. Further
study is needed to clarify the relationship between
elevation of body and hypothalamic temperature and
decreased motoneuron excitability.
Central Influences
. A theory by Haugen, Dixon, and
Dickel (1960) may explain the tranquilizer effect of low
intensity exercise. The theory states that random and
variable proprioceptive stimuli would allow normal
cortical activity, while consistent exposure to
excessively strong stimuli may induce arousal. Low
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intensity exercise, as suggested previously, also allows
normal cortical activity, which in turn, may induce
relaxation (deVries, 1981) . However, it is the high
intensity exercise which is particularly associated
with the tranquilizer effect (Bulbulian & Darabos, 1986)
.
These exercise effects may best be understood by focusing
on central and peripheral factors. Extensive reviews by
Bonnet, Requin and Semjen (1981) and McCrea (1986)
confirm these possibilities which are too detailed to
list completely in this review. However, both of these
reviews refer to the importance of presynaptic inhibition
or excitation upon motoneuron excitability. In group la
alpha-motoneuron inhibition occurs when excitatory post-
synaptic potentials (EPSP) are decreased via augmentation
of presynaptic inhibition or elevated through a lowered
level of tonic presynaptic inhibition (McCrea, 1986)
.
One theory which incorporates the influences of both
la and lb afferents upon motoneuron excitability is the
"moto servo" theory (Houk, 1979) . lb afferents are
influenced by muscle tension changes while la afferents
are controlled through variations in muscle spindle
length. The product of muscle tension and length is
referred to as a measure of muscle "stiffness" which is
controlled by la and lb afferents. An explanation of
these occurrences has been summarized by Bonnet et al.
(1981) . The changes in excitability along the reflex
pathway include: a) stretch sensitivity of muscle
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spindles governed by gamma motoneuron activity,
b) spindle transmissions to alpha-motoneurons controlled
by spinal interneuron inhibition, and c) alpha-motoneuron
excitability which determines reflex response amplitude.
Endorphins
. Another theory for exercise induced
relaxation is the production of endorphin-related
tranquilization during exercise. Endorphins reportedly
reduce pain and lend a sense of euphoria through a
morphine-like effect (Grossman & Sutton, 1985; Morgan,
1985)
.
Many anecdotal accounts support these views
without any valid human data. Work by Pert and Bowie
(1979) involved five minutes of forced swimming in an ice
bath by rats. Results indicated an increase in opiate
receptor occupancy, an indication of increased release of
endorphins. Support for this theory was noted when the
opiate antagonist naloxone was introduced to animal and
human subjects. Christie and Chesher (1982) found that
mice engaging in a regular swimming program seemed to
show physical addiction to exercise. This assumption was
formulated following the administration of naloxone. A
development of symptoms similar to withdrawl from drug
addiction occured among the mice. Similar findings
occurred when rats and human subjects were tested for
pain duration.
Shyu, Andersson, and Thoren (1982) reported that
pain or squeak threshold was elevated in rats following
exercise. Rats were exercised for seven kilometers/night
for three to four weeks. During the first hour of
15
running the squeak threshold was elevated and remained so
til the following morning. The elevation in threshold
was reflected by the amount of running. The squeak
threshold was decreased following six hours of inactivity
or naloxone treatment . These findings suggest that
exercise may induce an analgesic effect via central
endorphin mechanisms.
Haier, Quaid, and Mills (1981) tied a 3 lb. weight
to each subjects finger until pain was reported.
Subjects then ran one mile. Following exercise, subjects
given 10 mg of nalaxone reported pain more rapidly than
subjects receiving placebo. Endorphin release possibly
blocked by the drug, thereby attenuated the opiate
effect. However, no conclusive evidence confirms that
opiate receptor occupancy is attributed to exercise
induced tranquilization. Clearly more data is needed for
proper interpretation of endorphin related decreases in
motoneuron pool excitability.
Monoamine Theory
. Other neurotransmitters such as
norepinepherine (NE) and serotonin (5-HT) have been
altered in animal brains following exercise. Barchus and
Freedman (1962) attained significant alterations in brain
levels of NE and 5-HT following an acute bout of
swimming. Brown and Van Huss (1973) and Brown, Payne,
Kim, Moore, Krebs, and Martin (1979) found increased
levels of NE and 5-HT in rat brains following interval
training as compared to sedentary controls. It is
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interesting to note that benzodiazepine tranquilizers are
believed to exert there relaxant effects through
alterations in 5-HT transmission; however, evidence
supporting these claims is inconclusive (Nutt & Cowen,
1987) .
Tranquilizers and Exercise
The previous work of deVries (1981) mentioned the
tranquilizer effect of exercise and Morgan (1985) has
referred to the morphine-like properties of endorphins.
Tranquilizers are known to reduce CNS excitability as
measured by the H-reflex (Brunia, 1973; Gassel, 1973)).
In 1972, deVries and Adams compared a tranquilizing drug
(meprobamate) and certain forms of exercise. Five
conditons were used: 1)400 mg of meprobamate,
2) placebo; 400 mg of lactose prepared in identical
capsule form
, 3) 15 minutes of walking at a heart rate
of 100 BPM, 4) 15 minutes of walking at a heart rate of
12 BPM, and 5) control; where the subject sat and read
for an equivalent amount of time. Pre-trial tests were
completed during disturbed or undistured conditions.
Disturbed conditions involved completing problems using
arithmetic, while undisturbed trials lacked this
stressor. Post-tests occurred 30, 60, and 90 minutes
following the pre-test. Results indicated that exercise
was more effective in reducing muscular tension than
meprobamate. Exercise at a heart rate of 100 BPM showed
reductions of 20%, 2 3%, and 20% during the three post-
trials, while meprobamate and placebo showed no
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significant difference from controls. Exercise at a
heart rate of 120 BPM showed less effectiveness. It was
concluded that single doses of specific low intensity-
exercise may reduce muscle tension more effectively than
meprobamate. However, methodological errors cloud proper
interpretation of these data.
Triazolam
Triazolam is a hypnotic drug with a short mean
plasma half-life of 2.3 hours which ranges from 1.7-3.0
hours (Physicians Desk Reference, 1985) . Peak blood
concentrations of triazolam tablets diluted in water to
concentrations of .0083% occur at approximately .5 hours
(Pugsley & Cohon, 1982) . Triazolam is rapidly and
efficiently absorbed by humans with a short elimination
half-life (2.3-4.5 hrs.) which shows no significant
accumulations when administered once daily for one week
(Pugsley & Cohon, 1982). At 8.25 hours after intake
performance of psychomotor and cognitive skills returned
to baseline levels while at 10 hours a facilitation of
these skills occurred (Roth, Roehrs, & Zorick, 1983)
.
The action of benzodiazepines appears to be located
almost solely in the CNS. Therefore, the drug binds
specifically to receptors found only in the brain. At
these receptor sites a relaxation effect is promoted by
enhancement of the neurotransmitter gamma-aminobutyric
acid (GABA) . Common side effects include: a) drowsiness,
b) dizziness, and c) lightheadedness; however, these
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effects are subject to individual variation (Physicians
Desk Reference, 1985) . Previous data indicate that
triazolam effects are rapid, as is the elimination of
this substance.
Summary
Several studies were reviewed which demonstrated
reductions in tension following exercise. The H/M ratio
appears to be an accurate measure for detecting changes
in neuromuscular tension. Studies using this method
report a decrease in motoneuron excitability following
exercise, referred to as a tranquilizer effect. Proposed
mechanisms for this effect were presented. These
included a drug-like condition attributed to endorphin
release which produces relaxation, central influences,
and elevated body temperature and monoamines. However,
when exercise is compared to a tranquilizer, the data
seem inconsistent with current findings and predicted
drug induced effects. Therefore, further investigation
is needed to determine if exercise and drugs have
differences in their effects on muscle tension reduction.
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CHAPTER 3
METHODS
This chapter presents the experimental methods for
selecting subjects, metabolic and neuromuscular
measurement, drug preparation and administration, and
research design and statistical analysis.
Subjects
Eight college males, aged 22-3 years and possessing
a fitness level which allowed them to engage in 20
minutes of treadmill running at 75% of V02max, were
volunteers. A questionnaire was administered to
eliminate those potential subjects with contraindications
for heart disease and drug interactions. Subjects filled
out an informed consent document explaining the rights,
benefits, and dangers relating to the experimental
procedures and provisions for maintaining the privacy of
each subject. The document was also verbally reviewed.
Continuation of the experiment occurred only after the
subject read, understood, and signed the consent form.
Testing Schedule
Subjects reported after fasting for 10-12 hours to
the exercise physiology laboratory on 5 different
occasions separated by a minimum of 2 days. The first
visit a consisted of general orientation and a conference
regarding informed consent. A graded maximal oxygen
consumption test was also administered to determine
running speed for future trials.
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The four subsequent visits consisted of each of the
following conditons. Each session began with the
measurement of baseline H/M ratios followed by one of
four randomly assigned trials as follows:
Trial 1- Exercise at 75% V02max with post testing
under placebo conditions
Trial 2- Exercise at 75% V02max with post testing
under drug conditions
Trial 3- Triazolam administration followed by post
testing
Trial 4- Placebo administraion followed by post
testing
Exercise bouts consisted of 20 min. of running at
75% V02max intensity on a treadmill as determined by each
subject's V02max test.
Triazolam and placebo administrations were performed
double-blind immediately following exercise and non-
exercise trials.
Following the control or exercise periods the H/M
ratio was measured at 3 minutes. The literature
indicates mean peak blood concentrations of triazolam are
attained at one half hour post ingestion (Pugsley &
Cohon, 1982) ; exercise effects also appearing
approximately 30 minutes after exercise (dt^Vries & Adams,
1972) .
Measurement of the H/M Ratio
Neuromuscular excitation was estimated using the H/M
21
ratio (Angel & Hofmann, 1963) and modified by Hugon
(1973) . Tests consisted of electrical stimulation of the
tibial nerve at the popliteal fossa using an indifferent
lead and stimulating electrode. The indifferent lead was
an electrocardiogram (ECG) plate electrode located 15
centimeters above the popliteal fold on the posterior
thigh. The stimulating electrode, was a 1.5 cm disc
electrode in the popliteal fossa. Prior to securing the
stimulating electrode a probe electrode was used to find
the location that produced the maximum H-wave response at
a specific stimulus intensity. Single square wave
impulses of 0.5 msec duration were applied using an
electric stimulator (Grass S 44) via a stimulation
isolation unit (Grass SIU5) . A 20-30 second interval
separated each trial. Stimulation voltage was selected
by choosing a threshold value which produced an M-wave.
This voltage was increased in 5 volt increments until a
plateau M value was reached. Peak M-wave values were
accepted when three consecutive stimuli produced no
further increases in M-wave amplitude. The H-wave was
initially identified during determination of the M-wave
amplitude and then more precisely evaluated by retracing
its normal 10-15 stimulus volt range with stimulation
increments of 1.0 volt. Oscilloscope sensitivity was
increased when appropriate to improve resolution in the
peak H-wave recording. The re-examination of the H-wave
at 1.0 volt increments provided assurance that the
maximum H-wave amplitude was not missed between wider 5.0
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volt increases used during initial H-wave location and
maximal M-wave measurement. Further care was taken to
ensure accurate H-wave determination by recording two
readings at each 1.0 volt increment. The stimulus
voltage which produced the largest mean H-wave was then
used to record eight additional peak H-wave recordings.
After completion of this procedure the high and low
scores were eliminated and an overall mean peak value was
calculated (Bowles, 1987)
.
An electromyograph (EMG) , using two 1.5 cm disc
electrodes in a bipolar arrangement, recorded the H- and
M-waves. The active electrode was placed on the midline
of the leg over the soleus while the reference electrode
was placed proximal to the medial malleolus. The ground
electrode was placed proximal to the lateral malleolus.
The skin beneath the electrode sites was abraded using
sandpaper to ensure interelectrode resistance no higher
than 5000 ohms. Before measurement of MAP'S, subjects
were moved inside a copper plated cage to screen out 60
cycle interference. In addition to this procedure,
calibration of the recording equipment via a standardized
calibration signal took place prior to each testing
period. Muscle action potentials were then amplified
*-.hrough a Coulbourn Instruments Hi Gain
Bioamplifier/Coupler with a gain of 100 displayed and
stored on a storage oscilloscope (Tektronix (T912)) from
which the M- and H-wave amplitudes were measured.
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For exercise and control trials the indifferent lead
and stimulating electrodes were removed. To ensure
accurate reproductions of pre-trial data, electrode
locations were marked for replacement during post-trial
measurements
.
Maximal Oxygen Uptake
Subjects ran on a Quinton treadmill to attain
maximum oxygen uptake (V02max) . Tests consisted of three
two-minute stages at 0% grade using three ascending
speeds ranging from five to nine mph depending upon each
subject's normal training pace. These stages provided
three V02 values which were plotted and a regression
equation was derived to determine running speed at 75%
V02max. Following these three stages, continuous
collection of V02max data began. A speed from the former
trials which simulated normal training pace was held
constant while a 2 . 5% elevation of grade occurred each
minute until V02max was reached. Expired air was
analyzed every thirty seconds of each stage for oxygen
and carbon dioxide content by a Beckman OM-11 and LB-2
analyzer, respectively. The expired air volumes were
recorded simultaneously by an Alpha Technologies
Ventilation Meter.
Research Design and Statistical Procedures
Data analysis consisted of evaluating differences
among groups both before and after treatments. The order
of administration of treatments to subjects was
counterbalanced to control for carryover effects.
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Table 1
Latin Square Design for Subjects and Treatments
Periods
1 2 3 4
Subj ects Treatments
BS 3 4 2 1
CH 4 1 3 2
BL 2 3 1 4
JN 1 2 4 3
FJ 2 4 1 3
GM 4 3 2 1
JK 3 1 4 2
DB 1 2 3 4
Randomized block design with one-way treatment structure
was used to test for intergroup differences on pre-
treatment and post-treatment results. The .05 level of
significance was used for decision making.
25
CHAPTER 4
RESULTS
This chapter presents the results and data analysis
and is divided into six main sections: a) physical
characteristics of subjects, b) H- and M-wave responses,
c) raw data on H/M ratios, d) oxygen consumption during
exercise, e) group comparisons of pre- and post- tests,
and f) changes in H/M ratios from pre- to post-tests.
Physical Characteristics of Subjects
The physical characteristics of the subjects are
summarized in Table 2. Mean age, weight, and height of
subjects was 25.1 years, 180.0 cm, and 69.6 kg,
respectively. The mean V02 max was 71.3 ml*kg"-^*min~-'-.
Table 2
Physical Characteristics of Subjects
Subject Age Height Weight V02max
(cm) (kg) (ml*kg~ *min~ )
BS 25 180.3 71.8
CH 25 175.3 66.4
BL 22 185.4 70.5
JN 30 182.9 72.3
FJ 24 170.2 63.7
GM 28 182.9 73.2
JN 22 180.3 63.6
DB 25 182.9 75.0
Mean 25.1 180.0 69.6
SD+ 2.7 5.0 4.4
68.8
58.0
80.0
74.6
74.6
70.7
80.6
63.2
71.3
7.9
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Typical H^ and M-wave Responses
The typical stimulus-response pattern which is
created by the recorded H- and M-waves is shown in
Figure 1. The H-wave appears at a lower range of
stimulus voltages, quickly peaks and then disappears as
the M-wave begins to increase in magnitude. The H-wave
varied between and within subjects as a significant
difference across all treatments was noted (p > o.OOl).
The M-wave will normally plateau and remain stable upon
reaching its maximal value following the occlusion of H-
wave readings. This stability allows the M-wave to serve
as a control measure. The data show no significant
differences in M-wave changes across all trials
(p > 0.4268). From the maximal H- and M-waves the H/M
ratio is derived by dividing the maximal H-wave recorded
by the maximum M-wave recorded.
I
a.
10 20 30 40 so 60 70 80 90 100 110 120
Stiwului ( volts )
Figure 1: Plots of typical H- and M-waves. Stimulus is
shown in volts and H- and M-wave amplitude is shown as
mxllivolts.
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Raw Data
The data for H- and M-waves are given for each
subject in Tables D-1, D-2 , D-3 and D-4 (see Appendix D)
.
Trials are divided into: a) pre- /post-treatments, b)
exercise/non-exercise, and c) drug/placebo trials. H/M
ratios and the changes following treatment are also
given for pre- and post-measurements.
Oxygen Consumption During Exercise
The oxygen consumption for exercise trials is
presented in Tables E-1 and E-2 (see Appendix E) . Oxygen
consumption was measured during minutes 8-9, 9-10, 18-19,
and 19-20 of each 20-minute exercise bout. Mean oxygen
consumption was computed at the end of each two minute
period. Mean oxygen consumption values for condition T
(triazolam) and P (placebo) , their combined average
(grand mean)
,
and the percent of V02max the combined
average represents is given in Table E-3 (see Appendix
E)
.
The mean oxygen consumption was 76.2 ml*kg~''"*min~^
with a range of 70.3 to 81.0 ml*kg"-'-*min~-^.
H/M Ratio Changes in Response to Exercise
The following sections will present the results of
pre-and post-treatment analysis followed by the results
of each treatment condition.
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Table 3
A Comparison of Pre- and Post- H/M Ratio Means
and Mean Changes (MC)
Time NEX T EX T NEX P EX P
Pre- 63.2+28.4 59.1+22.3 67.2+31.0 61.6+27.6
Post- 69.2+28.4 *54.2+26.2 71.9+29.3 *55.7+26.4
MC 6.0 -4.9 4.7 -5.9
* indicates significant differences between post-means
Pre-Treatment H/M Ratios
Pre-treatment ratios were recorded in millivolts
before each treatment (see Appendix D) . Mean values
ranged from 59.1+22.3% to 67.2+31.0% for the four
experimental conditions. Mean values for drug trials
were 63.2+22.4% for non-exercise (NEX T) and 59.1+22.3%
for exercise (EX T)
. Means for non-exercise (NEX P)
placebo trials were 67.2+31.0% and 61.6+27.6% for
exercise (EX'P) under placebo conditions. An analysis of
variance one-way randomized block design was used to
determine group differences. Statistical analysis
revealed a significant difference between subjects
(p < 0.0001), but no differences between groups as shown
by Table 4. These finding indicate there were no
significant intergroup differences in H/M ratios prior to
the treatments.
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Table 4
Analysis of Variance for the Pre-test H/M Ratio
Dependent Variable: Pre-Ratio
Source df Sum of Squares Mean Square F value p>F
Model 16 1.75 0.11
Error 15 0.21 0.01
Total 31 1.97 P
7.87 0.0001
Root MSB 0.1181
Source df Type IV SS F value p > F
Subject 7 1.66 16.93 0.0001
Period 3 0.01 0.15 0.9278
Exercise 1 0.03 2.07 0.1709
Drug 1 0.01 0.76 0.3973
Exercise*Drug 1 o.OO 0.02 0.8999
Post-Treatment H/M Ratios
The post-treatment H/M ratios were analyzed
following treatments using an analysis of variance one-
way randomized block design. Mean values for the non-
exercise conditions were 69.2+28.4% and 71.9+29.3 for
drug and placebo, respectively. Exercise conditions
showed mean values of 54.2+2 6.2 for placebo trials and
55.7+26.4 for drug trials. Analysis of variance on post-
test scores yielded a significant overall inter-group
difference (0.0008). Table 5 provides a summary of this
test. Both exercise groups were significantly different
from the non-exercise groups and that the drug and
placebo conditions showed no differences.
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Table 5
Analysis of Variance for Post-Treatment H/M Ratios
Dependent Variable: Post-Ratio
Source df Sum of Squares Mean Square F value p > F
Model 16 2.23 0.14
Error 15 0.16 0.01
Total 31 2.39
12.41 0.0001
Root MSE 0.1059
Source df Type I SS F value p > F
Subject 7 1.87
Period 3 0.03
Exercise l 0.19
Drug 1 0.00
Exercise*Drug 1 0.00
23.83 0.0001
0.77 0.5301
17.41 0.0008
0.01 0.9213
0.05 0.8314
Mean Changes (MC)
Consistent with previous studies, the exercise and
non-drug condition showed a reduction, in this case an
H/M ratio reduction of 5.9%. This was the largest mean
reduction in H/M ratio and the only trial in which all
subjects showed a consistent reduction in H/M ratio. The
change in H/M ratio when exercise and drug were combined
showed a 4.9% mean reduction with all but five of eight
subjects showing a reduced H/M ratio.
In the non-exercii?e drug condition the H/M ratios
changed from 63.2 to 69.2% with six subjects showing
increased H/M ratios. Under placebo conditions the
common non-exercising pattern appeared with a mean
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increase of 4.7% in H/M ratio. Six subjects displayed an
increase in H/M ratio.
Summary of Results
Results indicated the following:
1) No differences existed between groups prior to
the first treatment condition.
2) Post-treatment conditions revealed a significant
difference (p < 0.0008) between exercise and non-exercise
conditions.
3) Exercise groups were significantly different from
non-exercise groups while no drug effect existed among
treatments
.
4) Mean changes from pre- to post-trials disclosed
reductions in H/M ratios during exercise and elevations
during non-exercise treatments.
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CHAPTER 5
SUMMARY, DISCUSSION, AND CONCLUSIONS
This chapter consists of a summary, discussion and
interpretation of results, conclusions, and
recommendations for future research.
Summary
Studies comparing reductions of neuromuscular
tension through exercise or drugs show limited and
inconclusive results. The purpose of this study was to
examine the potential tranquilizer effect of exercise and
triazolam on motoneuron excitability and associated
neuromuscular tension as measured by the H/M ratio.
Eight male subjects were randomly assigned to one of
four separate treatments. Trials consisted of drug and
placebo conditions with or without 20 minutes of
treadmill running at 75% of V02max. Using a repeated
measures ANOVA pre- and post- treatment H/M ratios were
evaluated to determine treatment effects. Post hoc
intergroup comparisons revealed an exercise effect among
both exercise groups while no drug effect emerged across
all groups.
The hypotheses projected reductions in H/M ratios
following drug administration, exercise, and an enhanced
tranquilizer effect following the combined trial of drug
and exercise.
Post hoc results only partially supported the
hypotheses indicating that differences in mean post- H/M
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ratios occurred with exercise. Exercise trials under
drug conditions showed post-mean treatment
differences; however, the hypothesis of enhanced
reduction through a drug and exercise combination did not
appear. Non-exercising drug and placebo conditions
showed no post-treatment differences.
Discussion of Exercise Results
This study indicated that exercise at 76.2% of
V02max would promote neuromuscular tension reduction and
decreased motoneuron pool excitability as measured by the
H/M ratio. Exercise post-trial means differenced from
non-exercise post-trial means. Several studies
have reported similar reductions through a variety of
exercise modes and intensities (deVries, 1968; deVries et
al., 1981; deVries & Adams, 1972; Bulbulian & Darabos,
1986; Bowles, 1987). In one of the first studies of
execise effects on muscle relaxation, deVries (1968)
found that bench stepping decreased activity in the
biceps by 58% as recorded by EMG. deVries et al. (1981)
tested the effects of cycling exercise on the centrally
occurring reflexes influenced by muscle tension. Once
again, a reduction of 18.7% in muscle tension was found
leading deVries to conclude that exercise acted as a
"tranquilizer effect" and decreased motoneuron
excitability. However, only one study, deVries and Adams
(1972) has directly tested tranquilizers against exercise
for decreased neuromuscular activity. Peak drug and
exercise effects were not matched which clouded results.
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An exercise effect of reduced MAP'S again occurred.
Post-treatment comparisons of H/M ratios occurred at a
time which allows physiological effects of drugs and
exercise to be assessed. The present study indicated
that exercise conditions brought about the greatest
reduction in motoneuron excitability and neuromuscular
tension as measured by post- H/M ratios. When
comparisons are made using mean changes (MC) , the
exercise placebo condition was the only trial which
produced a drop in post-treatment H/M ratios for all
subjects. These results are in agreement with studies
mentioned in the previous section. The results of the
present study simulates the finding of Bulbulian and
Darabos (1986) . However, a difference between the
percent reduction exists as Bulbulian and Darabos (1986)
report a 21.5% reduction in spinal motoneuron activation
while only a 5.9% decrease is shown in the present study.
One possible explanation for this discrepancy in
magnitude may be the unusually high ratios produced in
the current study's subject pool due to differences in
methodology. Two subjects were consistently within a
range of 8 0% to 100% or above. The highest ratio
attained by Bulbulian and Darabos (1986) was 49.7% which
was exceeded by all trial means in the present study. As
noted earlier, individuals which initially have lower
ratios may have a greater predisposition for attaining
decreased excitability. This predisposition is evident
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when JK is compared to subject DB. Within this trial (EX
P) subject JK's pre- treatment ratio is 104.5%. Post-
exercise results show a dramatic reduction to 85.9%.
However, DB pre- tested at 28.6% and after exercise
dropped to 19.0%. Further research establishing
predictive equations for predispositions within subjects
towards lower H/M ratios needs exploration.
Results indicate a 4.9% reduction in H/M ratio
during the drug condition. The post- H/M ratios for
subjects under this condition ranged from 8.6% to 93.6%.
The 10.4% reduction is the largest change of any trial in
this experiment. The subject which attained this value
may be predisposed to relaxation as mentioned earlier.
Five of eight subjects have decreased values in this drug
trial. Increases again seem minute with values of +0.8%
to 2.7%. When EX T is compared to NEX T there seems to
be a general trend towards H/M ratio reduction as opposed
to increase, respectively, indicating an ability of
exercise to "mask" drug effects. For example, subject FJ
had a post- H/M of 111.6% and MC of 16.8 in NEX T, but
during EX T post- values were 93.6% and MC equal to 2.5%.
The values, while still positive, appeared to be
moderately subdued. ANOVA results indicate that this
relationship proved to be insignificant. However, the
data show that three possible effects may have occurred
including: a) small elevations in the H/M ratio resulting
from drug administration are reversed by exercise, b)
larger increases in the H/M ratio are attenuated through
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exercise, and c) decreases in the H/M ratio brought about
by the drug are augmented via exercise.
Subjective comments and attenuated drug reactions
seem to support the theory that exercise may reverse drug
effects. One subject following the EX T trial commented
that he "definitely did not receive the drug." Another
subject who lost motor functions in the NEX T trial made
no comments following the EX T trial and had no
noticeable impairments in coordination. One possible
explanation for this occurence may be the ability of the
body to override drug effects through either decending or
spinal inhibitory mechanisms as a result of exercise. An
alternative explanation may be an enhanced drug clearance
from the plasma following exercise. Discussion of
theories related to exercise reduction of motoneuron
excitability will follow.
Several hypotheses have been offered to explain
exercise induced reductions in motoneuron excitability
and neuromuscular tension. One theory cited for these
reductions is offered by Von Euler and Soderburg (1956;
1957)
.
Their work notes muscular relaxation in cats
following an increase in hypothalamic and total body
temperature. deVries (1968) reasoned that exercise would
elevate body temperature and thereby reduce neuromuscular
activity. This may be a mechanism for the present study,
however recent evidence by Bowles (1987) which matched
metabolic work in level and down-hill treadmill running
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found mean differences of 15.7% in post- H/M ratios.
Equal metabolic work should match temperatures, therefore
heat mechanisms may have limited effects on decreasing
neuromuscular activity.
Another possible explanation of the tranquilizing
effect of exercise may be due to random, intermittent
proprioceptive stimuli which allows normal cortical
activity (Haugen et al., 1960). Treadmill running would
appear to provide a source of incoming stimuli which may
be conducive to sound cortical activity.
Finally, endogenous opoid peptides may be
responsible for reductions in motoneuron pool
excitability and neuromuscular activity. Pert and Bowie
(1979) found increased opiate receptor occupancy in rats
after swimming. This may be interpreted as increased
endorphin release which is believed to promote feelings
of euphoria (Morgan, 1985) . The psychological state
noted during the release of endorphins may be linked to
decreased spinal excitation via descending inhibitory
responses or motoneuron pool inhibition. Further
research is needed before this hypothesis can be
established as a causal mechanism.
Discussion of Non-Exercise Results
The non-exercise trials failed to elicit a
difference in post-treatment H/M ratios. Post- H/M
ratios in both drug and placebo conditions were elevated
when compared to post-exercise ratios.
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When using mean change (MC) comparisons the NEX T
trial unexpectedly showed a 6.0% mean increase in the
post- H/M ratio. Six subjects showed an increased post-
trial response. The two remaining subjects showing post-
treatment drops also recorded the lowest pre-test values
indicating a possible predisposition for tension
reduction. However, the magnitude of these drops were
very small at -3.8% and -3.4%. Another important
observation within these data which should be discussed
are the H/M ratios which exceed 100%. These elevated
values have been shown in a previous study and an
explanation has subsequently been offered (Bowles, 1987)
.
Bipolar placement of recording electrodes
allowing a field of pickup including the triceps surae
and peroneals combines both muscles MAP's. A condition
seemingly elevating H-wave responses in excess of M-wave
values reflecting 100% recruitment of the triceps surae
muscle. This conditon seems to be present in a small
percentage of subjects.
The drug effects on H/M ratios would appear to be
opposite of predicted results since the tranquilizer
triazolam would be expected to show a decreased H/M
response. Analysis of variance revealed no drug effect
during post-treatment comparisons which is surprising
since triazolam, is a known muscle relaxant (Kroboth &
Juhl, 1983; Roth et al., 1983). These results are also
in contrast to a previous study in which a similar
tranquilizer, diazepam, was linked to a decreased H-
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reflex response (Brunia, 1973) . However, it has been
shown that small doses of a similar benzodiazepine
(diazepam) have actually improved psychomotor skills
(Mattila, 1984) . This may be interpreted as
disinhibition of inhibitory drug mechanisms that
centrally influence the motoneuron pool. The precise
mechanisms by which triazolam promotes relaxation effects
is still unclear, however the actions of benzodiazipines
appear to cause inhibitory activities upon the central
nervous system (CNS) via the neurotransmitter gamma-
aminobutyric acid (GABA) (Kroboth & Juhl, 1983)
.
Exercise reductions imitate this process through unknown
disinhibitory mechanisms. With inhibition removed, the
motoneurons become less resistant to excitatory responses
and spinal excitation.
Results indicate that an increase from 67.2 to 71.9%
occurred in the H/M ratio during non-exercise placebo
trials. Two subjects showed a decrease, one of which
appears to be somewhat substantial at -8.7% The other
value is once again minimal at -2.9%. Only individual
variation can be offered as an explanation for the large
drop of the one subject. The mean increase observed in
the present study during non-activity supports several
previously reported EMG and H/M ratio data (deVries,
1968; Ebert, 1986; deVries et al., 1981; Bulbulian &
Darabos, 1986; Bowles, 1987). deVries (1968) found a
23.7% increase in control EMG data which appeared after
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one hour of inactivity. deVries et al. (1981) found
subjects had an increase of 1.2% in post- H/M ratios
following 2 minutes of sitting while Bulbulian and
Darabos (1986) found increases of 2.11%. A recent study
by Bowles (1987) with closely related methodology found
an increase of 12.6%. Evidence of neuromuscular
excitability increases lasting up to one hour during
control conditions support the probability that spatial
differences have no appreciable effect upon the results.
The elevated control trials by Bowles lend additional
support to this assumption. Analysis of variance in the
present study also appears to support this hypothesis as
placebo differences were found to be insignificant. The
absence of proprioceptive stimuli, anticipation of future
post- testing, lack of distraction, and cortical
influences could have contributed to elevated motoneuron
pool excitability (Haugen et al., 1960; Bahrke &
Morgan, 1978)
.
Conclusions
Within the limits of this study, it is concluded
that exercise is more effective in reducing motoneuron
excitability and neuromuscular tension than triazolam
ingestion. Also, triazolam ingestion does not affect
motor neuron excitability when taken in conjunction with
exercise.
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Recommendations for Future Research
The following related research is recommended:
1. Further evaluation of the H/M ratio to determine
validity of this measure.
2. Replication of the present study with other drugs
and/or dosages. Ideally, the drug dosage should be large
enough to produce inhibitory rather than excitatory
responses.
3. Determine if subjects with lower initial pre-test
H/M scores have a predisposition for tension reduction.
4. The replication of the present study with a more
stringent control period.
5. A biochemical analysis of exercise effects at the
cellular level which identifies possible neurotransmitter
mechanisms, such as serotonin, involved in reduction of
motoneuron excitability and neuromuscular tension.
6. A comparison of exercise and drug effects between
trained and untrained subjects.
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Appendix A
EXERCISE AND TRIAZOLAM QUESTIONAIRRE
Please read the following questions silently to
yourself making no verbal or written responses. If you
answer "yes" to any question without specifying which one,
please inform the experimenter that you would rather not
participate in this study. No questions will be asked.
1. Are you currently taking any prescribed diuretics (a
drug which decreases water retension)
,
parabrom, or ammonium
chloride?
2
.
Within the past 12 hours prior to testing have you
consumed any coffee, tea, hot chocolate or cola which
contains caffeine?
3. Have you ever had an allergic reaction to
tranquilizers?
4. Do you have any history of heart disease?
5. Do you have any history of high blood pressure
(above 140/90)?
6. Do you smoke?
7. Are you diabetic?
8. Does your family have a history of heart disease
prior to the age of 50?
9. Do you have an elevated total cholesterol/ HDL ratio
(above 5)?
10. Have you consumed any alcohol or ethanol within the
past 12 hours (prior to testing)
?
11. Are you currently taking cimetidine?
12. Have you eaten within the past 12 hours (prior to
testing)
?
13. Are you epileptic?
14. Are you currently taking any psychotropic,
anticonvulsant, anti-histaminic or any other CNS depressant
medications?
15. Are you currently taking any prescribed, non-
prescibed or illegal drugs?
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Appendix B
INFORMED CONSENT
voluntarily consent to
participate in this study which compares a tranquilizing
drug (triazolam) and exercise effects on muscle tension
reduction. Muscle tension will be measured using a surface
electrode which will elicit a noticable but not painful
shock to the back of the knee to initiate a muscle
contraction. The electrical activity of this muscle twitch
will be recorded before and 3 minutes after the drug
administration or exercise trials. Exercise trials will be
20 minutes in duration at submaximal effort. Ingestion of
placebo or tranquilizer solutions will occur after each
exercise trial. Drug trials will consist of ingestion
placebo or tranquilizers solutions, followed by no exercise
and muscle tension testing 3 minutes later.
During the first of 5 visits, a maximal oxygen uptake
test will be given to determine future exercise loads. The
test wil start slow and progressively become more difficult
until maximum effort and resulting fatigue causes
termination of the test. This will typically take 10-15
minutes and can cause discomforts such as fatigue,
breathlessness, and muscle soreness. Risks include personal
injury during treadmill running, cardiac abnormalities or
arrest. These risks are decreased by readily available
emergency numbers and phones, CPR certification of the
tester, and screening of participants before testing via
questionairre
.
The drug received is triazolam which is a fast acting
tranquilizer. A .25mg dose will be in a solution which is
ingested after the randomly selected trial. Since the
possibility of drowsiness, dizziness, or lightheadedness may
occur, the experimenter will deliver each subject home
safely. Subjects are encouraged to stay home under
supervision of another adult for the remainder of the day.
No subject will be allowed out of the lab alone following
any trial. About 10 of 1000 patients using triazolam have
noted discomforts of headache, nervousness, ataxia, or
stomach upset. With chronic use of up to 42 days less than
1% have experienced euphoria, tachycardia, tiredness,
confusion, cramps, depression and visual disturbances. Less
than .5% have had constipation, taste changes, diarrhea, dry
mouth, dermatitis, sleep disturbances, paresthesia,
tinnitus, dysesthesia, weakness, and congestion. Risks
include allergic reactions to triazolam, addictive effects
when coupled with other CNS depressing drugs, antereograde
amnesia with theraputic doses (which are much stronger than
subjects will receive) , and hepatic failure occurred in one
subject using diuretic drugs. Screening of the subject's
drugs intake before the experiment through the questionairre
should eliminate these risks. If any adverse effects from
the drug should occur, emergency personnel will be
contacted.
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I, the undersigned, understand the procedures which
have been explained and my questions have been answered. I
also understand the following:
1. The risks and discomforts involved with this
experiment.
2. The benefits of this experiment to me are knowledge
of my own personal fitness level and learning if
exercise can effectively replace drugs to relieve
neuromuscular tension.
3. I understand that in the event of injury during this
experiment, no financial compensation will be available
since state regulations prohibit Kansas State University
from carrying insurance for such situations.
4. If I have any questions regarding this experiment, I
am free to contact the project director. Brent Stauth or Dr.
Ronald Bulbulian (532-6765)
.
5. I am free to withdraw my participation from this
experiment at any time without prejudice towards me.
6. All results will be confidential by encoding data
sheets and storing the code in a seperate location from the
experimental data. It will be available to me upon request.
Signature Date
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Appendix C
GUIDELINES FOR SUBJECTS RECEIVING TRIAZOLAM
Subjects must follow the proceeding guidelines and be
aware of the precautions listed below to ensure personal
safety.
1. After being delivered home following testing you
must stay home under adult supervision for at least eight
hours. After this time period normal physical and mental
functions should return. A call to your home will be made
to ensure this.
2. Triazolam has been shown to cause drowsiness and
dizziness. Therefore, activities requiring balance and
perception such as driving, operation of machinery, or
excessive walking must be avoided for the entire eight hour
period. It is suggested that you sleep, watch TV, or read
while sitting at home.
3. No other drugs can be combined with triazolam. The
physician supervising this experiment has noted that the
dosage used would appear extremely safe. However,
detrimental side effects including one death has occurred
when another drug was taken in addition to triazolam.
Stomach discomforts and headache may accompany the use of
triazolam. Do not take any medication (i.e. aspirin, alka
seltzer) to relieve these discomforts. They will dissipate
with time. If any complications arise contact Brent Stauth
at 532-6765 (office) or 776-2420 (home) or the Lafene
Student Health Center Emergency Service at 532-6544.
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Appendix D
Raw Data
Table D-1
H- and M-wave Amplitudes and H/M Ratios for Non-
Exercise Triazolam Conditions (NEX T)
.
Subject H M H/M H M H/M %C
Pre-NEX T Post-NEX T
BS 3.5 8.6 40.7 3.3 8.4 39.3 -3.4
CH 5.2 8.0 65.0 6.0 8.2 73.2 12.6
BL 4.0 7.6 52.6 3.8 7.1 53.5 1.7
JN 6.4 8.9 71.9 7.5 8.4 89.3 24.2
FJ 7.3 7.7 94.8 7.7 6.9 111.6 17.7
GM 7.0 9.6 72.9 7.6 10.1 75.2 3.2
JK 7.1 8.7 81.6 7.8 9.0 86.7 6.3
DB 2.5 9.6 26.0 2.4 9.6 25.0 -3.8
Mean 5.4 8.6 63.2 5.3 8.5 69.2 7.3
SD+ 1.9 0.8 22.4 2.2 1.1 28.4 10.1
* recordings are in millivolts
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Table D-2
H- and M-wave Amplitude and H/M Ratios for
Exercise Triazolam Conditions (EX T)
.
Subject H M H/M H M H/M %C
Pre-EX T Post-EX T
BS 5.4 9.2 58.7 4.5 8.0 56.3 -4.3
CH 4.1 7.4 55.4 3.5 7.4 47.3 -14.6
BL 3.3 7.2 45.8 2.5 6.1 41.0 -10.5
JN 5.6 8.3 67.5 4.2 8.6 48.8 -27.7
FJ 7.2 7.9 91.1 7.3 7.8 93.6 2.7
GM 4.4 8.3 53.0 4.7 8.8 53.4 0.8
JK 7.1 8.6 82.6 7.5 8.9 84.3 2.1
DB 1.6 8.4 19.0 0.7 8.1 8.6 -54.7
Mean 4.8 8.2 59.1 4.4 8.0 54.2 -13.3
SD+ 1.9 0.6 22.3 2.3 0.9 26.2 19.7
* recordings are in millivolts
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Table D-3
H- and M-wave Amplitudes and H/M Ratios for
Non-Exercise Placebo Conditions (NEX P)
.
Subjects H M H/M H M H/M %C
Pre-NEX P Post-NEX P %C
BS 4.3 9.0 47.8 5.3 9.0 58.9 23.2
CH 6.4 8.8 72.7 6.0 8.6 69.8 -4.0
BL 3.0 6.5 46.2 3.7 5.9 62.7 35.7
JN 4.6 8.0 57.5 4.1 8.4 48.8 -15.1
FJ 8.4 7.2 116.7 8.6 7.3 117.8 0.9
GM 4.2 8.1 51.9 6.1 8.9 68.5 32.0
JK 9.6 8.6 111.6 10.0 8.8 113.6 1.8
DB 2.9 8.8 33.0 3.3 9.4 35.1 6.4
Mean 5.4 8.1 67.2 5.9 8.3 71.9 10.1
SD+ 2.5 0.9 31.0 2.4 1.1 29.3 18.2
* recordings are in millivolts
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Table D-4
H- and M-wave Amplitudes and H/M Ratios for
Exercise Placebo Conditons (EX P)
.
Subjects H H H/M H M H/M %C
Pre-EX P Post-EX P %C
BS 3.3 9.0 36.7 2.6 10.0 26.0 -29.2
CH 3.8 7.9 48.1 3.6 8.5 42.4 -11.9
BL 3.6 8.8 40.9 3.0 9.6 31.3 -23.5
JN 5.4 8.4 64.3 5.0 8.5 58.8 -8.6
FJ 8.0 8.8 90.9 8.3 9.3 89.2 -1.9
GM 8.1 10.3 78.6 7.5 10.0 75.0 -4.6
JK 9.2 8.8 104.5 7.9 9.2 85.9 -17.8
DB 2.4 8.4 28.6 1.6 8.4 19.0 -33.6
Mean 5.5 8.8 61.6 4.9 8.8 55.7 -16.4
SD+ 2.6 0.7 27.6 2.6 1.2 26.4 11.6
*recordings are in millivolts
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Appendix E
Oxygen Consumption During Exercise
Table E-1
Oxygen Consumption During Exercise Triazolam Trials (EX T)
Exercise T Oxygen Consumption (ml*kg~ *min~ )
Ss 8-9min 9-lOmin Mean 18-19min 19-20min Mean
55.2 54.7 57.7 56.0 56.8
47.0 46.1 48.8 48.2 48.5
60.9 61.0 64.1 66.3 65.2
55.8 56.8 64.6 62.4 63.5
54.2 55.0 55.2 55.2 55.2
54.0 54.0 53.7 54.3 54.0
63.4 63.1 59.1 60.3 59.7
44.1 44.0 44.9 44.0 44.5
54.3 54.3 56.0 55.8 55.9
6.4 6.6 6.9 7.3 7.1
BS 54.2
CH 45.2
BL 61.1
JN 57.8
FJ 55.8
GM 53.9
JK 62.8
DB 43.8
Mean 54.3
SD+ 6.8
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Table E-2
Oxygen Consumption During Exercise Placebo Trials (EX P)
Exercise P Oxygen Consumption (ml*kg~ *min~ )
Ss 8-9min 9-lOmin Mean 18-19min 19-20min Mean
54.7 51.7 52.3 53.6 52.9
40.6 39.9 42.6 39.9 41.4
60.5 60.9 65.8 64.9 65.3
61.2 59.7 61.8 61.3 61.6
53.1 53.5 56.5 57.4 57.0
54.7 53.4 55.4 54.6 55.0
57.6 57.6 59.5 59.4 59.5
43.3 43.5 46.7 44.6 45.6
53.2 52.5 55.1 54.5 54.8
7.5 7.5 7.7 8.4 8.0
BS 48.8
CH 39.1
BL 61.2
JN 58.2
FJ 53.9
GM 52.2
JK 57.6
DB 43.8
Mean 51.9
SD+ 7.6
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Table E-3
Mean Oxygen Consumption for Trial T and Trial P, Grand
Mean, and Exercise Intensity Across All Trials
Mean V02 (inl*kg~-'-*min~"'')
Subject EX T EX P Mean Percent of V02inax
BS 55.8 52.3 54.1 78.6
CH 40.7 47.3 44.0 75.8
BL 63.1 63.1 63.1 78.9
JN 60.1 60.6 60.4 81.0
FJ 55.1 55.2 55.2 73.9
GM 54.0 54.2 54.1 76.5
JK 61.4 58.5 60.0 74.4
DB 44.2 44.6 44.4 70.3
Mean 54.3 54.5 54.4 76.2
SD+ 8.0 6.4 7.1 3.4
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Abstract
Previous work comparing the role of tranquilizers
and exercise on the reduction of muscle tension has shown
limited and inconclusive results (deVries & Adams, 1972)
.
The purpose of this study was to examine the effects of
exercise and triazolam on neuromuscular tension reduction
as measured by the H/M ratio. Eight male subjects
participated in four separate trials: a) placebo
administration, b) drug administration, c) exercise
followed by placebo administration, and d) exercise
followed by drug administration. Exercise performed was
20 minutes of treadmill running at 75%V02max. Pre- and
post-trial muscle tension was assessed by artificially
stimulating the tibial nerve producing variable H/M
ratios. Analysis of data using a repeated measures ANOVA
with a Latin Square treatment design on both pre- and
post-test scores found a significant exercise effect
(p < 0.0008). Post hoc intergroup comparisons using
Fisher's least significant test supported exercise
effects by finding both exercise group means
significantly lower in H/M ratios when compared to non-
exercised group means. Failure to support expected drug
effects and enhanced exercise effects using drugs and
exercise in combination appeared when no significant
differences in H/M ratios followed across all triazolam
trials. Future research should include replication of
this study using other drugs and/or dosages, comparisons
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of exercise and drug effects on H/M ratios in trained and
untrained subjects, and the identification of
neurotransmitters involved with reductions of
neruomuscular tension.
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